MISSING leadership by WHO Director Dr Margaret Chan

Test and treat Hepatitis C now!

Director-General Chan, in 2010, the Executive Board of the World Health Assembly tasked you with mobilizing political will and adequate resources for an effective response to the global viral hepatitis pandemic.

New hepatitis C virus (HCV) drugs coming out of the pipeline have demonstrated cure rates of up to 100%; the hepatitis C virus could feasibly be eradicated from the planet. Without World Health Organization (WHO) at the helm, this prediction will remain unattainable.

Since 2010, more than a million people have died from HCV although it is treatable and curable. Three to four million people are newly infected each year, although HCV is preventable. Most new infections occur among people who inject drugs, yet less than 4% of them have sufficient access to clean injecting equipment. This shocking public health failure allows the epidemic to continue spreading.

Only a tiny fraction of the 185 million people who have HCV are aware of it. Most live in low and middle-income countries (LMICs) and have no access to diagnostics, care, or treatment. Pegylated interferon (PEG-IFN), backbone of the current standard of care for HCV, is priced cruelly out of reach. Where there is access to HCV treatment, people who inject drugs are often denied it: merely 2-4% of people who inject drugs access treatment.

People who inject drugs who want to be treated for HCV are often forced to stop their drug use or enter an opioid substitution therapy (OST) program. Neither of these stipulations are justifiable on clinical grounds, but are forms of discrimination that stem from the moral judgment of people who inject drugs. People who are currently injecting or in an OST program respond as well to HCV treatment as those who are not.

The World Health Organization must act to increase global access to HCV diagnostics and treatment, in particular for people who inject drugs, by:

  • Speaking out frequently on the need for rights-based harm reduction services including needle and syringe programs (NSP), OST and integrated hepatitis C treatment on a scale that will reverse the HCV epidemic among PWID as recommended by WHO/UNAIDS/UNODC.
  • Providing technical support to countries to create access to affordable, high quality, effective and safe biosimilar and alternative pegylated interferon products.
  • Creating clear guidance on HCV screening and testing that explicitly recommends screening for people living with HIV, in whom HCV progresses rapidly, and in people who inject drugs.

Many countries are prepared to address their HCV epidemics, and we, people living with HCV and our advocates, are ready to be actively involved in the development of national plans to prevent and control HCV. Countries are waiting for WHO guidance in key areas that will empower us all to move forward.

You must not fail your mandate. We implore you to demonstrate true leadership through the mobilization of political will and the necessary resources to combat the global HCV epidemic.

Sign on


Attached documents

Document

PDF – 355 kb

1828 supporters

  • Barre-Sinoussi Francoise

    France

  • Barrett John

    Hep C Support

    United States

  • Barrios Juan Ramon

    Asociacion Omsida

    Spain

  • Barros de Melo Adriano

    Grupo Otimismo

    Brazil

  • barry sean

    VOCAL-NY

    United States

  • BARTHELEMY Stéphanie

    AIDES

    France

  • Bartlett Sofia

    Kirby Institute

    Australia

  • Bartomeus Ramon

    Spain

  • Barón Tena Rosa Mª

    Spain

  • Basheeib Taib

    Reachout Centre Trust

    Kenya

  • Batchelder Abigail

    United States

  • Battaglia Gwen

    Hepatitis C Global Initiatives (HepCGI)

    United States

  • Baxter David

    Pharmacotherapy Advocacy & Action Team

    Australia

  • Baxter David

    Canberra Alliance for Harm Minimisation & Advocacy

    Australia

  • Bayoud Raymond

    HepCatVision

    United States

  • Bazak Marek

    Poland

  • Bazak Zofia

    Poland

  • bazargan naseem

    Philadelphia FIGHT

    United States

  • Bearpark Ruth

    Hepatitis NSW

    Australia

  • Beauverie Patrick

    Médecins du Monde

    France

  • Beddoe Simon W

    Indian Drug Users Forum

    India

  • Beegun Priya

    Mauritius

  • Behle Hans

    Elterninitiative für akzeptierende Drogenarbeit und humane Drogenpolitik Wuppertal

    Germany

  • Behle Heidrun

    Bundesverband der Eltern und Angehörigen für akzeptierende Drogenarbeit e. V.

    Germany

  • beigel Patty

    Hepatitis411/Studio makeup

    United States

  • Beistegui Jose luis

    Spain

  • Beistegui chirapozu Jose luis

    Privado

    Spain

  • Bellen Anja

    Germany

  • bellera montse

    Spain

  • Belli Francesca

    AIDES

    France

  • Bellido Alfredo

    Spain

  • Bellina de los Heros Javier

    Foro Salud

    Peru

  • bello arcaus gerardo

    cuentapropista

    Uruguay

  • Bellón Baamonde Agustín

    http://asscat-hepatitis.org/

    Spain

  • Belondrade Karine

    World Hepatitis Alliance

    United Kingdom

  • Beltov Martin

    Bulgaria

  • Belyqevq Olgq

    ASTAU

    Ukraine

  • Benaarab Salah eddin

    ALCS

    Morocco

  • Benson Sharon

    South Court Primary Care Centre (NSP)

    Australia

  • Benzacar Andrea

    United States

  • Beokovic Djurdja

    HRONOS

    Serbia

  • Berg Amelia

    SHARPS

    Australia

  • Beridze Miniko

    television

    Georgia

  • berman stuart

    United States

  • bermudez fer evaristo

    Spain

  • Bernal Coromina Carme

    Spain

  • BERNARD LOURENÇO CABRAL

    ORGANIZAÇÃO PRÓ-FÍGADO

    Brazil

  • Bershadsky Svetlana

    Community Organization Union Amicus

    Ukraine

  • BERTRAND FREUND

    France

  • Bertrand Ludivine

    France